Market closed

Penumbra/$PEN

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Penumbra

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.

Ticker

$PEN

Trading on

NYSE

Industry

Health Care Equipment & Supplies

Employees

4,200

Penumbra Metrics

BasicAdvanced
$9.3B
Market cap
273.90
P/E ratio
$0.89
EPS
0.54
Beta
-
Dividend rate
$9.3B
0.54
$277.34
$148.00
322K
5.821
3.049
19.217
20.528
51.73%
3.33%
3.13%
273.904
8.063
8.43
9.99
69.933
16.96%
-15.96%
17.88%
-0.53%

What the Analysts think about Penumbra

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Penumbra stock.

Penumbra Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Penumbra Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PEN

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Penumbra stock?

Penumbra (PEN) has a market cap of $9.3B as of December 22, 2024.

What is the P/E ratio for Penumbra stock?

The price to earnings (P/E) ratio for Penumbra (PEN) stock is 273.9 as of December 22, 2024.

Does Penumbra stock pay dividends?

No, Penumbra (PEN) stock does not pay dividends to its shareholders as of December 22, 2024.

When is the next Penumbra dividend payment date?

Penumbra (PEN) stock does not pay dividends to its shareholders.

What is the beta indicator for Penumbra?

Penumbra (PEN) has a beta rating of 0.54. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.